Verified peer comparison
Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) vs Safehold Inc. New Common Stock Financial Comparison
Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) versus Safehold Inc.…
Direct answer
Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) and Safehold Inc. New Common Stock are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) Revenue
- 386,013,000 USD
- Safehold Inc. New Common Stock Revenue
- 385,552,000 USD
- Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) Operating income
- -291,322,000 USD
- Safehold Inc. New Common Stock Operating income
- 307,584,000 USD